Adult acute myeloid leukemia with T(15;17)(Q22;Q12)
Clinical trials for Adult acute myeloid leukemia with T(15;17)(Q22;Q12) explained in plain language.
Never miss a new study
Get alerted when new Adult acute myeloid leukemia with T(15;17)(Q22;Q12) trials appear
Sign up with your email to follow new studies for Adult acute myeloid leukemia with T(15;17)(Q22;Q12), keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
Genom att skicka in godkänner du våra Användarvillkor
-
Could a Gene-Targeting drug boost chemo for older leukemia patients?
Disease control CompletedThis study tested whether adding a drug called oblimersen to standard chemotherapy (daunorubicin and cytarabine) helps older adults (60+) with untreated acute myeloid leukemia live longer or achieve remission. About 500 participants were randomly assigned to receive chemo with or…
Matched conditions: ADULT ACUTE MYELOID LEUKEMIA WITH T(15;17)(Q22;Q12)
Phase 3 • Sponsor: National Cancer Institute (NCI) • Aim: Disease control
Last updated Jun 27, 2026 13:02 UTC
-
New Two-Step transplant shows promise for blood cancer patients
Disease control CompletedThis study tested a two-step stem cell transplant for people with blood cancers like leukemia and lymphoma. First, patients received low-dose chemotherapy and radiation to prepare their bodies. Then, they got donor stem cells followed by drugs to prevent the donor cells from atta…
Matched conditions: ADULT ACUTE MYELOID LEUKEMIA WITH T(15;17)(Q22;Q12)
Phase 2 • Sponsor: Sidney Kimmel Comprehensive Cancer Center at Thomas Jefferson University • Aim: Disease control
Last updated Jun 27, 2026 12:08 UTC
-
Drug duo shows promise for Tough-to-Treat leukemia
Disease control CompletedThis phase II trial tested two drugs—sirolimus and azacitidine—in 57 people with high-risk myelodysplastic syndrome (MDS) or acute myeloid leukemia (AML) that had come back or didn't respond to standard treatment. The goal was to see if the combination could shrink or control the…
Matched conditions: ADULT ACUTE MYELOID LEUKEMIA WITH T(15;17)(Q22;Q12)
Phase 2 • Sponsor: Sidney Kimmel Comprehensive Cancer Center at Thomas Jefferson University • Aim: Disease control
Last updated Jun 27, 2026 08:03 UTC